Leica SPX5 2-photon laser-scanning confocal microscope system
Leica SPX5 2-photon laser-scanning confocal microscope system
批准号:
7838159
负责人:
James Douglas Engel
金额:
$120.05万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-06 至 2011-05-05
关键词:
Cell physiologyCellsChromosome StructuresCommunitiesComputer softwareConfocal MicroscopyDevelopmentFundingHousingImageImage AnalysisInstructionIonsLaboratoriesLasersLifeMaintenanceMichiganMicroscopeMicroscopyNamesNeoplasm MetastasisOrganismPhotobleachingPhotonsPhototoxicityProcessProviderRequest for ApplicationsResearchResearch PersonnelSapphireScanningServicesStudentsSupervisionSystemTimeTitanUnited States National Institutes of HealthUniversitieshearing impairmentinstrumentationinterestmembertumor
中文摘要
描述(由申请人提供):本申请申请资金用于购买Leica SP5X双光子激光扫描共聚焦显微镜系统,用于密歇根州安娜堡的密歇根大学校园。目前,密歇根大学还没有共享使用的双光子共聚焦显微镜系统。该系统由一台徕卡SP5X倒置显微镜组成,该显微镜配置为接受相干超II泰坦蓝宝石红外激光进行双光子成像。该系统是共聚焦显微镜的一种新形式,它允许对生物体系统、细胞、分子和感兴趣的离子分布进行实时重复成像,同时避免了与传统共聚焦显微镜相关的光漂白和光毒性问题。徕卡系统之所以被选中,是因为它在发射光谱选择方面的技术进步,操作软件的易用性,以及当地服务提供商的快速技术援助。该系统将被安置在显微镜和图像分析实验室(MIL)内,这是一个专业管理的大学范围内的成像核心,(www.milimaging.com)。我们预计,将有多达70名NIH资助的主要研究者、他们的共同研究者、学生以及密歇根大学校园内研究社区的其他人对NIH的进步有技术上的兴趣。将受益于该仪器的项目包括树突和轴突发育机制、细胞分泌过程、染色体组织、听力损失和肿瘤转移过程等。日常维护、技术监督和指导将由军情部的工作人员进行。持续的维护将通过军事部队使用的标准补给系统进行,长期的连续性将由军事部队的指定储备基金提供支持。
英文摘要
DESCRIPTION (provided by applicant): This application requests funds to purchase a Leica SP5X 2-photon laser-scanning confocal microscope system for the University of Michigan campus in Ann Arbor, Michigan. Currently there is no 2-photon confocal microscope system for shared use at the University of Michigan. The system consists of a Leica SP5X inverted microscope configured to accept a Coherent ultra II Titan Sapphire IR laser for 2-photon imaging. This system is a newer form of confocal microscopy which allows real-time repeated imaging of living organism systems, cells, molecules, and ion distribution of interest while avoiding the photobleaching and phototoxicity problems associated with conventional confocal microscopes. The Leica system was selected because of its technological advancements with emission spectral selection, ease of operating software, and fast technical assistance from local service providers. The system will be housed within the Microscopy & Image Analysis Laboratory (MIL), a professionally managed University- wide imaging core, (www.milimaging.com). We anticipate that up to 70 NIH sponsored primary investigators, their co-investigators, and students as well as others in the research community on the University of Michigan campus have uses which are of technical interest to NIH advancements. Projects that will benefit from the instrumentation include mechanisms for dendritic and axonal development, secretory processes of cells, chromosomal organization, hearing loss, and tumor metastasis processes to name a few. Day-by-day maintenance, technical supervision, and instruction will be carried out by members of the MIL staff. Ongoing maintenance will be covered through a standard recharge system used in the MIL. Long-term continuity is supported by a designated reserve fund for the MIL.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of Michigan Kidney, Urology and Hematology Research Training Network
-
批准号:10506490
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2022
-
负责人:James Douglas Engel
-
依托单位:
Administrative Core
-
批准号:10627773
-
项目类别:
-
资助金额:$21.5万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
Administrative Core
-
批准号:10164855
-
项目类别:
-
资助金额:$21.65万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
Identification of novel y-globin corepressors and advanced inhibitor development
-
批准号:10164854
-
项目类别:
-
资助金额:$47.24万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
Administrative Core
-
批准号:10400175
-
项目类别:
-
资助金额:$21.57万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
Identification of novel y-globin corepressors and advanced inhibitor development
-
批准号:10627770
-
项目类别:
-
资助金额:$47.09万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
Targeting Enzymatic Regulation of Fetal Hemoglobin Repression
-
批准号:10627766
-
项目类别:
-
资助金额:$215.78万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
Targeting Enzymatic Regulation of Fetal Hemoglobin Repression
-
批准号:10164849
-
项目类别:
-
资助金额:$217.41万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
Targeting Enzymatic Regulation of Fetal Hemoglobin Repression
-
批准号:10400171
-
项目类别:
-
资助金额:$216.52万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
Identification of novel y-globin corepressors and advanced inhibitor development
-
批准号:10400174
-
项目类别:
-
资助金额:$47.16万
-
财政年份:2019
-
负责人:James Douglas Engel
-
依托单位:
20th Hemoglobin Switching Conference
-
批准号:9197787
-
项目类别:
-
资助金额:$5.5万
-
财政年份:2016
-
负责人:James Douglas Engel
-
依托单位:
19th Hemoglobin Switching Conference
-
批准号:8785769
-
项目类别:
-
资助金额:$1.45万
-
财政年份:2014
-
负责人:James Douglas Engel
-
依托单位:
The 18th Hemoglobin Switching Conference
-
批准号:8319727
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2012
-
负责人:James Douglas Engel
-
依托单位:
GATA3 regulation in transcriptional networks during hematopoietic cell developmen
-
批准号:8300343
-
项目类别:
-
资助金额:$38.74万
-
财政年份:2012
-
负责人:James Douglas Engel
-
依托单位:
Inactivation of LSD1 as a possible treatment for sickle cell disease
-
批准号:8319822
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2012
-
负责人:James Douglas Engel
-
依托单位:
GATA3 regulation in transcriptional networks during hematopoietic cell developmen
-
批准号:8416960
-
项目类别:
-
资助金额:$36.42万
-
财政年份:2012
-
负责人:James Douglas Engel
-
依托单位:
Inactivation of LSD1 as a possible treatment for sickle cell disease
-
批准号:8442767
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2012
-
负责人:James Douglas Engel
-
依托单位:
GATA3 regulation in transcriptional networks during hematopoietic cell developmen
-
批准号:8603835
-
项目类别:
-
资助金额:$38.74万
-
财政年份:2012
-
负责人:James Douglas Engel
-
依托单位:
The 16th Hemoglobin Switching Conference
-
批准号:7536929
-
项目类别:
-
资助金额:$5.05万
-
财政年份:2008
-
负责人:James Douglas Engel
-
依托单位:
The 4th International Conference on GATA Factors and Human Disease
-
批准号:7331528
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2007
-
负责人:James Douglas Engel
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: